|
FearLess in NeuroOncology
RECRUITINGN/ASponsored by Virginia Commonwealth University
Actively Recruiting
PhaseN/A
SponsorVirginia Commonwealth University
Started2025-06-24
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06989086
Summary
The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: Patients: * Self-report a diagnosis of a primary malignant brain tumor (grade II-IV) * \>2 weeks post-cranial resection or biopsy * Elevated Fear of Recurrence Distress Rating * Primarily English speaking * \>/= 18 years of age at the time of enrollment Caregivers: * nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV) * Elevated Fear of Recurrence Distress Rating * Primarily English speaking * \>/= 18 years of age at the time of enrollment Exclusion Criteria: Patient / Caregiver Exclusion: * Cognitive impairment that might prohibit active intervention engagement * Inability to understand and provide informed consent * Inability to attend virtual sessions due to unstable or no internet connection
Conditions6
AstrocytomaCancerCaregiverGlioblastoma (GBM)OligodendrogliomaPrimary Malignant Brain Tumor
Locations1 site
Virginia Commonwealth University
Richmond, Virginia, 23298
Ashlee Loughan, PhDashlee.loughan@vcuhealth.org
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorVirginia Commonwealth University
Started2025-06-24
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06989086